ARCHIVES

DePinho’s Letter to CPRIT’s Gimson, And Gimson’s Response

This article is from The Cancer Letter archive.

Vol. 38 No. 22 | June 1, 2012

Download PDF Visit The Full Archive

Related Articles

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

In Brief: Senate Committee Confirms Varmus; Albertini Directs Vermont Cancer Center

November 19, 1993

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

March 3, 1989

White House Gives FDA Authority Over Tobacco Product Sales

August 18, 1995

Chabner Object To Yarbro’s Remarks On Federal Role In Clinical Research

April 15, 1983

NCAB Hears Good News: FY 92 Budget Allows NCI To Increase Levels Of Most Programs

November 29, 1991